GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Locked. A moderator closed replies on this one. It stays up because the content above the argument is worth keeping.
129
c/glp1aus·posted 2 months ago by u/blunt_coldbox_2024

genuine question about TGA that I am slightly embarrassed to ask

Discussion

Trying to get a straight answer on this: genuine question about TGA that I am slightly embarrassed to ask.

Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.

Assumed the New Zealand position applied here. It does not, and someone corrected me politely with the actual source.

Rang three pharmacies for a private price and got three different numbers, all in the same city.

Screenshot none of this. Read the whole thread, including the parts where I am told I am wrong.

178 up / 49 down78% upvoted17 commentsid 1867bg5 May 2026

17 comments

13 in this archive, depth 5

best — the order this archive was captured in

u/jarno_cabrera20 points·2 months ago

Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.

replysharereportpermalink
u/blunt_coldbox_20249 points·2 months ago

That is a pharmacy-level stock issue rather than a national supply issue. They feel identical and are not.

replysharereportpermalink
[removed]4 points·2 months ago

[removed by moderator]

replysharereportpermalink
u/blunt_coldbox_2024OP2 points·2 months ago

What did the pharmacy quote for the private price?

replysharereportpermalink
u/mod_cold_roommod · c/coldchain1 point·2 months ago

Is this about registration or about subsidy?

replysharereportpermalink
u/hedda_adeyemi8 points·2 months ago

Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.

replysharereportpermalink
u/gustav_solberg0 points·2 months ago

Not convinced. That is the New Zealand position and the thread is asking about Australia.

replysharereportpermalink
u/tuva_kirchner1 point·2 months ago

PBS criteria are published and searchable

replysharereportpermalink
u/kenji_kimani9 points·2 months ago

Push back: the compounded arrangements changed and the advice you are quoting predates the change.

replysharereportpermalink
u/lane_watchermod · logistics7 points·2 months ago

Yes — the shortage database is the source. The news coverage of it is downstream and usually a week behind.

replysharereportpermalink
u/tl_dr_tina0 points·2 months ago

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

replysharereportpermalink
u/aussie_pbs_watchMOD4 points·2 months ago

Flagged as describing the superseded compounded arrangements — left up with a note rather than removed.

replysharereportpermalink
u/usp_appendixcompendial3 points·2 months ago

Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.